v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Cash flows from operating activities:    
Net loss $ (8,389,525) $ (15,046,075)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation - stock options 1,927,243 4,657,139
Stock-based compensation - stock issued for services 52,960
Non-cash interest expense 8,364,805 189,613
Depreciation and amortization 622,074 1,469,119
Non-cash operating lease costs 83,414 115,843
Bad debt expense 72,563 14,464
Loss on assets held for sale 3,349,799
Change in fair value of derivative liability (5,467,610)
Loss on extinguishment of convertible notes 863,669
Other 1,751 117,066
Changes in operating assets and liabilities:    
Accounts receivable 170,219 2,084,860
Inventory 161,586
Contract assets (35,391) 42,942
Prepaid expenses and other assets (243,157) 144,392
Accounts payable and accrued expenses (2,777,383) (433,905)
Lease liabilities (75,192) (97,850)
Deferred revenue (473,772) 551,385
Net cash used in operating activities (5,303,332) (2,679,622)
Cash flows from investing activities:    
Purchases of property and equipment (83,095)
Net cash used in investing activities (83,095)
Cash flows from financing activities:    
Proceeds from sales of common stock, net of offering costs 2,684,754 154,947
Proceeds from stock option exercises 2,171
Proceeds from exercises of warrants 655,000
Proceeds from loans payable 4,273,823
Proceeds from convertible notes payable 5,000,000
Proceeds from line of credit 6,270,625 2,564,589
Payments on line of credit (6,473,657) (374,483)
Payments on loans payable (1,658,754) (3,406,538)
Payments of debt issuance costs (1,408,642) (144,000)
Net cash provided by financing activities 5,071,497 3,068,338
Effect of exchange rates on cash and cash equivalents (59,214)
Net (decrease) increase in cash and cash equivalents (231,835) 246,407
Cash and cash equivalents - beginning of the period 992,589 1,062,442
Total cash and cash equivalents, end of period 760,754 1,308,849
Reconciliation of cash and cash equivalents:    
Cash and cash equivalents from continuing operations 760,754 1,118,282
Cash and cash equivalents included in assets of business held for sale 190,567
Cash paid for:    
Interest 556,679 1,083,769
Income taxes
Supplemental disclosures of non-cash investing and financing activities:    
Common stock issued in exchange for services 91,000
Common stock issued as a lending discount 122,000
Conversion of convertible notes $ 8,988,669